Assets
History
2021: Purchase of Ortho Clinical Diagnostics Honey for $6 billion
On December 23, 2021, it became known that the manufacturer of tests for COVID-19 Quidel agreed to buy Ortho Clinical Diagnostics for about $6 billion. The transaction value per share of the sold company is $24.68 per share, which is a surcharge of 24.7% to the quotation rate at the end of exchange trading on December 22. The price of the transaction included $2 billion in debts of Ortho Clinical. More details here.
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |